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Abstract
Objectives: Recent studies of margin-related recurrence have raised questions on the necessity of
ensuring wide resection margins in the resection of colorectal liver metastases. The aim of the current
study was to determine whether resection margins of 10 mm provide a survival benefit over narrower
resection margins.
Methods: A total of 425 laparoscopic liver resectionswere carried out in 351 procedures performed in 317
patients between August 1998 and April 2012. Primary laparoscopic liver resections for colorectal
metastases were included in the study. Two-stage resections, procedures accompanied by concomitant
liver ablations and one case of perioperative mortality were excluded. A total of 155 eligible patients were
classified into four groups according to resection margin width: Group 1, margins of < 1 mm [n = 33,
including 17 patientswith positivemargins (Group 1a)]; Group 2,margins of 1 mm to < 3 mm (n = 31); Group
3, margins of ≥ 3 mm to < 10 mm (n = 55), and Group 4, margins of ≥ 10 mm (n = 36). Perioperative and
survival data were compared across the groups. Median follow-up was 31 months (range: 2–136 months).
Results: Perioperative outcomes were similar in all groups. Unfavourable intraoperative incidents
occurred in 9.7% of procedures (including 3.2% of conversions). Postoperative complications developed
in 11.0% of patients. Recurrence in the resection bed developed in three (1.9%) patients, including two
(6.1%) patients in Group 1. Rates of actuarial 5-year overall, disease-free and recurrence-free survival
were 49%, 41% and 33%, respectively. Median survival was 65 months. Margin status had no significant
impact on patient survival. The Basingstoke Predictive Index (BPI) generally underestimated survival. This
underestimation was especially marked in Group 1 when postoperative BPI was applied.
Conclusions: Patients with margins of < 1 mm achieved survival comparable with that in patients with
margins of ≥ 10 mm. When modern surgical equipment that generates an additional coagulation zone is
applied, the association between resection margin and survival may not be apparent. Further studies in
this field are required. Postoperative BPI, which includes margin status among the core factors predicting
postoperative survival, seems to be less precise than preoperative BPI.
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Introduction
Colorectal carcinoma (CRC) is one of the most common of malig-
nant tumours and accounts for at least one million new cases
worldwide each year. Haematogenous spread to the liver occurs in
40–60% of CRC patients.1 Liver resection is generally accepted as
the standard of care and may cure patients with colorectal metas-
tases, resulting in 5-year survival rates of up to 58%.2 At present, the
use of a laparoscopic approach to liver resection is increasing.1,3–8
The introduction of laparoscopic surgery has been accompa-
nied by the rapid adoption of new dissection equipment for
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parenchymal liver transection.9 Concerns related to margin status
have emerged with particular relation to the widespread increase
in the use of parenchyma-sparing techniques.10
The present report describes a large-scale retrospective study
that aimed to determine whether the achievement of a wide resec-
tion margin of 10 mm provides a survival benefit over narrower
resection margins.
Materials and methods
Patients and data collection
Between 18 August 1998 and 27 April 2012, 425 laparoscopic liver
resections were performed in 317 patients during 351 procedures at
the Intervention Centre and Department of Hepatopancreato-
biliary Surgery, Oslo University Hospital (Rikshospitalet, Oslo,
Norway). In this series, 267 laparoscopic liver resections were
performed for colorectal metastases in 186 patients during 205
procedures. Repeat resections (n = 36), liver resections combined
with radiofrequency ablation or cryoablation (n = 11), two-stage
resections (n = 2) and occurrences of perioperative mortality
(n = 1) were excluded from the research analysis. A total of 155
patients were eligible for inclusion in the study. The data were
obtained from a prospectively collected database and confirmed by
medical records and patient reviews.
Patients were classified into four groups according to resection
margin width: Group 1, margins of < 1 mm [n = 33, including 17
patients with positive margins (Group 1a)]; Group 2, margins of
≥ 1 mm to < 3 mm (n = 31); Group 3, margins of ≥ 3 mm to
< 10 mm (n = 55), and Group 4, margins of ≥ 10 mm (n = 36).
Patients were staged preoperatively using computed tomogra-
phy (CT) or magnetic resonance imaging (MRI) of the abdomen,
as well as chest X-rays or CT. In the latter period of the series,
selected patients underwent positron emission tomography (PET)
scanning to rule out extrahepatic disease. Patients were defined as
having synchronous metastases if they presented with secondaries
at the same time or within 6 months of the detection of their
primary tumour. The presence of extrahepatic disease amenable to
radical surgery was not considered a contraindication to resection.
To assess postoperative survival probabilities, patients were
scored using the Basingstoke Predictive Index (BPI), which repre-
sents a multifactorial 30-grade scoring system.11 One of the advan-
tages of this scoring system is that it enables both preoperative
and postoperative score calculation. The absence or presence of
margin status as a scoring factor (for which the redistribution of
score points in other cofactors compensates) accounts for differ-
ences in pre- and postoperative score calculations.
Unfavourable intraoperative incidents were graded on the basis
of the Satava approach to surgical error evaluation.12,13 Postopera-
tive complications were graded in agreement with the Accordion
classification (Clavien–Dindo–Strasberg classification).14
Neoadjuvant or adjuvant chemotherapy was applied according
to current guidelines. Palliative chemotherapy was offered to
patients with inoperable disease during follow-up at the discre-
tion of the oncologist.
Mortality was verified using the Norwegian National Popula-
tion Register (Folkeregisteret).
Technique
The surgical technique used in the study centre has been described
in earlier publications.3,15 Intraoperative ultrasonography was
used to determine the final type of liver resection, as well as to
mark resection lines and identify additional lesions.
Parenchymal transection was most frequently performed using
a bipolar coagulator (LigaSure®; Covidien, Inc., Norwalk, CT,
USA) or an ultrasonic dissector [AutoSonix® (Covidien, Inc.);
SonoSurg® (Olympus Corp., Tokyo, Japan); Harmonic® (Ethicon
Endosurgery, Inc., Blue Ash, OH, USA)] in combination with an
ultrasonic surgical aspirator (SonoSurg Aspirator® or CUSA®/
Selector®; Integra LifeSciences Corp., Plainsboro, NJ, USA). Ultra-
sonic dissectors were mostly used to achieve a superficial
parenchymal transection. Surgical clips (EndoClip®; Covidien,
Inc.) and the LigaSure® device were used in small and medium-
sized vessel transections, whereas the Endo-GIA® (Covidien, Inc.)
was applied in the transection of major vessels.
Pathologic examination and follow-up
Resection margins were reported macroscopically by the operat-
ing surgeon and confirmed by the pathologist after fixation in
formaldehyde. Microscopic evaluation was carried out by the
pathologist. The distance from the tumour to the closest resection
margin was measured in millimetres. In cases of multiple con-
comitant liver resections, the shortest margin to any of the
resected specimens was recorded as the final margin.
Patients were followed through outpatient appointments in
which they submitted to clinical examinations, CT of the
abdomen, CT of the thorax (or chest X-ray) and serum
carcinoembryonic antigen (CEA) assay every 4 months to 1 year
post-surgery, and every 6 months thereafter to 5 years or later if
necessary.
Patient follow-up data were updated and all research data were
ready for research analysis in July 2012.
Statistical analysis
Statistical analyses were carried out using spss Version 18 (SPSS,
Inc., Chicago, IL, USA). Data are given as the median (range) and
number (percentage) for perioperative parameters. Comparisons
among the groups were made using the chi-squared test for cat-
egorical data and the Kruskal–Wallis test for continuous clinical
outcomes. In the event of a verified statistical difference between
groups, the Dunn method was applied for all pairwise multiple
comparisons. Rates of 1-, 3- and 5-year survival were analysed
using the life tables method. The Kaplan–Meier method was
applied to calculate mean survival values and to construct survival
curves. The log-rank test was used to compare survival among the
groups.
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Results
Preoperative patient demographics and clinical features were
similar in all four groups (Table 1). The origin of the primary
CRC was the colon in 97 (62.6%) patients and the rectum in 58
(37.4%) patients. Six (3.9%) patients had CRC of Dukes tumour
stage A, 34 (21.9%) of Dukes stage B, 64 (41.3%) of Dukes stage C
and 39 (25.2%) of Dukes stage D. In 12 (7.7%) patients, the stage
of the primary tumour was unknown. Liver metastases were diag-
nosed synchronously in 91 (58.7%) patients. The groups differed
significantly in preoperative BPI (Table 1).
Table 2 shows the operative variables and perioperative out-
comes in the four groups of patients. Five (3.2%) of the 155
laparoscopic procedures were converted to open surgery because
of intra-abdominal adhesions (n = 2) or haemorrhage (n = 3).
There were no significant differences in perioperative outcomes
among the four groups. A total of 109 of 155 patients underwent
resection for a solitary metastasis. A total of 211 resections
were performed. There were 15 (9.7%) intraoperative incidents,
of which eight (5.2%) were of Grade I severity and seven (4.5%)
were of Grade II severity. There were no incidents of Grade III
severity.
Postoperative complications were observed in 17 (11.0%)
patients. These included four, two, seven and four instances of
complications of Grades I, II, III and IV, respectively. No instances
of Grade V or VI complications occurred (Table 2).
Three patients underwent synchronous resections for colorectal
cancer and liver metastases. Liver resection was combined with
cholecystectomy in 10 patients, adrenalectomy in two patients,
resection of metastases in the left renal hilum in one patient, and
left-sided salpingo-oophorectomy in one patient.
The median diameter of the resected metastases was 29 mm
(range: 4–120 mm). Formal hemi-hepatectomies were performed
in seven (4.5%) patients.
At final pathologic analysis, the resection margin was found
to measure < 1 mm (Group 1) in 33 (21.3%) patients. These
included 17 (11.0%) patients (Group 1a) with positive margins,
all of whom were classified as having R1 resections. Margins meas-
ured ≥ 1 mm and < 3 mm (Group 2) in 31 (20.0%) patients,
≥ 3 mm and < 10 mm (Group 3) in 55 (35.5%) patients and
≥ 10 mm (Group 4) in 36 (23.2%) patients. The median margin
width was 4 mm (range: 0–50 mm).
The median hospital stay was 3 days (range: 1–33 days).
After a median follow-up of 31 months (range: 2–136 months),
48 (31.0%) patients had died. Of the 17 patients with positive
margins, two (11.8%) patients died at 2 months and 13 months
after surgery, from diabetic nephropathy and multiple tumour
recurrence, respectively. Mean postoperative survival was
81 months. Actuarial 1-, 3- and 5-year overall survival was 84%,
64% and 49%, respectively (Fig. 1). Actuarial 1-, 3- and 5-year
disease-free survival was 61%, 45% and 41%, respectively. Actuarial
1-, 3- and 5-year recurrence-free survival was 48%, 35% and 33%,
respectively. There were no significant differences in survival among
the groups. Survival data for the respective patient groups and a
comparison between the observed actuarial survival values and the
values predicted by the BPI scoring system are presented in Table 3.
Tumour recurrence developed in 73 (47.1%) patients after a
median of 12 months (range: 2–44 months). Tumour recurrence
Table 1 Demographic and clinical features of patients submitted to laparoscopic liver resection for colorectal metastasis
Parameters Group 1
(margin:
< 1 mm)
(n = 33)
Group 2
(margin:
≥ 1 mm to
< 3 mm)
(n = 31)
Group 3
(margin:
≥ 3 mm to
< 10 mm
(n = 55)
Group 4
(margin:
≥ 10 mm)
(n = 36)
P-value Total
(n = 155)
Age, years, median (range) 66 (37–84) 65 (43–84) 64 (35–81) 69 (44–82) 0.689 66 (35–84)
Female/male, n 15/18 16/15 24/31 13/23 0.644 68/87
ASA score, median (range) 3 (1–3) 2 (1–3) 2 (2–4) 2 (2–3) 0.906 2 (1–4)
Preoperative BPIa, median (range) 7 (2–14) 5 (3–16) 8 (3–17) 11 (5–23) < 0.001 7 (2–23)
Metachronous/synchronous metastases, n 15/18 12/19 20/35 17/19 0.707 64/91
Dukes stage of primary tumour, A/B/C/D, n 1/6/15/6 1/10/8/9 2/11/28/11 2/7/13/13 0.383 6/34/64/39
(Not assessable or unknown) (5) (3) (3) (1) 12
Differentiation of primary tumour, good/moderate/poor, n 2/24/0 1/19/0 1/38/4 4/30/0 0.200 8/111/4
(Not assessable or unknown) (7) (11) (13) (2) 33
Number of tumours in the liver
1, n (%) 19 (58%) 20 (65%) 40 (73%) 30 (83%) 0.105 109 (70%)
≥ 2, n (%) 14 (42%) 11 (35%) 15 (27%) 6 (17%) 46 (30%)
Preoperative CEA, median (range) 16 (1–82) 15 (1–408) 18 (1–908) 13 (1–498) 0.956 15 (1–908)
Follow-up period, months, median (range) 22 (2–86) 33 (4–115) 33 (3–132) 45 (4–136) 0.150 31 (2–136)
aThe Dunn method verified a significant difference between Groups 2 and 4, and a significant difference between Groups 2 and 3.
ASA, American Society of Anesthesiologists; BPI, Basingstoke Predictive Index; CEA, carcinoembryonic antigen.
824 HPB
HPB 2014, 16, 822–829 © 2013 International Hepato-Pancreato-Biliary Association
in the liver occurred in 51 (32.9%) patients after a median of
9.5 months (range: 4–25 months), including three (1.9%) patients
who experienced local recurrence in the resection bed. Two of the
three instances of local recurrence were recorded in Group 1.
Among the 17 patients with positive margins, tumour recurrence
in the liver developed in eight (47.1%) patients, including one
(5.9%) patient with local recurrences.
There were no statistical differences among the four groups of
patients in rates of either overall or hepatic recurrence (P = 0.316
and P = 0.349, respectively). During follow-up, 36 patients were
treated for liver disease recurrences. A total of 30 patients later
underwent repeat liver resections of which 18 were performed by
laparoscopy and 12 by laparotomy. Six patients underwent sec-
ondary radiofrequency ablation or cryoablation (Table 4).
Significant differences in the rate of re-resection of the liver
were observed between Groups 1 and 3, and Groups 1 and 4
(P = 0.023). There were no significant differences among the
groups in terms of later treatments by local ablation for tumour
recurrences.
Discussion
Liver resection is generally accepted as the standard of care and
may provide a cure for patients with colorectal liver metastases.16
Several clinicopathologic factors have been established as
important determinants of treatment failure in colorectal liver
metastases,17 including the width of the resection margin.18,19
Most authors have reported that the resection margin is a sig-
nificant factor that influences both overall and disease-free
survival.17–20 In past decades, the risk for a resection margin of
< 10 mm has to a certain extent been considered to contraindi-
cate liver resection.21,22
Recent advances in surgical technique and anaesthesia have
enabled more patients to undergo hepatic resection. Despite
initial concerns about its oncologic adequacy, the laparoscopic
approach to the surgical treatment of malignant diseases, particu-
larly to colorectal metastases, has been found to achieve outcomes
comparable with those of conventional open resection.6,23–25 Com-
parative studies have concluded that there are no differences in
rates of margin-free resection or in the magnitude of resection
margins between laparoscopic and open liver resections.26 Despite
the routine use of intraoperative ultrasonography, the rate of
positive resection margins still ranges from 5% to 13% and the
width of the optimal liver resection margin is still controver-
sial.18,21,27,28 At present, a tumour-free margin is considered to be
adequate in the resection of colorectal metastases.16,17
A number of large series have analysed survival factors follow-
ing liver resection for colorectal metastases. Indeed, earlier studies
Table 2 Operative variables and perioperative outcomes in patients submitted to laparoscopic liver resection for colorectal metastasis
Parameters Group 1
(margin:
< 1 mm)
(n = 33)
Group 2
(margin:
≥ 1 mm to
< 3 mm)
(n = 31)
Group 3
(margin:
≥ 3 mm to
< 10 mm
(n = 55)
Group 4
(margin:
≥ 10 mm)
(n = 36)
P-value Total
(n = 155)
Operative time, min, median (range) 165 (60–357) 126 (29–390) 135 (41–488) 171 (43–488) 0.170 152 (29–488)
Intraoperative blood loss, ml, median (range) 300 (0–2000) 300 (0–3000) 200 (0–4000) 275 (0–4000) 0.580 250 (0–4000)
Unfavourable intraoperative events, n (%) 4 (12.1%) 2 (6.5%) 4 (7.3%) 5 (13.9%) 0.639 15 (9.7%)
Including Grade I 2 2 2 2 8 (5.2%)
Grade II 2 – 2 3 7 (4.5%)
Grade III – – – – –
Postoperative complications, n (%) 3 (9.1%) 2 (6.5%) 8 (14.5%) 4 (7.3%) 0.685 17 (11.0%)
Including Grade I 1 1 1 1 4 (2.6%)
Grade II – – 2 – 2 (1.3%)
Grade III 1 1 3 2 7 (4.5%)
Grade IV 1 – 2 1 4 (2.6%)
Grade V – – – – –
Grade VI – – – – –
Formal hemi-hepatectomy, n 1 1 3 2 0.921 7 (4.5%)
Size of largest tumour, cm, median (range) 2.5 (1.0–8.7) 2.5 (0.4–12.0) 2.5 (0.6–8.0) 3.4 (6.0–7.5) 0.400 2.9 (4.0−12.0)
Conversion, n (%) 2 (6%) 0 2 (3.6%) 1 (2.8%) 0.616 5 (3.2%)
Postoperative hospital stay, days, median (range) 2 (2.0–3.5) 3 (2.0–3.5) 3 (2.8–4.5) 3 (2.0–3.0) 0.622 3 (3.0–4.0)
Postoperative BPIa, median (range) 14 (2–19) 4.9 (2–12) 6 (2–13) 7 (4–18) < 0.001 6 (2–19)
aThe Dunn method verified a significance difference between Group 1 and all other groups, and a significant difference between Groups 2 and 4.
BPI, Basingstoke Predictive Index.
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indicated that survival rates were significantly better in patients in
whom resection margins of ≥ 10 mm were achieved than in those
in whom margins of < 10 mm were obtained.2,28,29 However, the
findings of many recent studies oppose this doctrine.16,17,19,20,28
The present study failed to demonstrate a beneficial effect of
margins of ≥ 10 mm. Interestingly, in the current series, patients
with resection margins of < 1 mm (Group 1) achieved a 5-year
survival rate of 54%, whereas patients with resection margins of
Figure 1 Kaplan–Meier curve for actuarial overall survival
Table 3 Survival: observed actuarial and predicted survival in patients submitted to laparoscopic liver resection for colorectal metastasis
Parameters Group 1
(margin:
< 1 mm)
(n = 33)
Group 2
(margin:
≥ 1 mm to
< 3 mm)
(n = 31)
Group 3
(margin:
≥ 3 mm to
< 10 mm
(n = 55)
Group 4
(margin:
≥ 10 mm)
(n = 36)
P-value Total
(n = 155)
Length of survival, months, mean (95% CI) 63 (49–75) 74 (54–95) 81 (63–99) 80 (61–100) 0.988 81 (73–89)
Actuarial 1-year OSa 86% 80% 87% 80% 84%
Actuarial 3-year OSa 72% 71% 61% 58% 64%
Actuarial 5-year OSa 54% 46% 53% 45% 49%
Expected 5-year OS based on preoperative BPI 42.4% 46.5% 37.2% 33.6% NA 39.2%
Expected 5-year OS based on postoperative BPI 30.9% 49.3% 44.8% 41.2% NA 42.1%
Actuarial 5-year disease-free survivala 36% 39% 49% 37% 0.978 41%
Actuarial 5-year recurrence-free survivala 30% 30% 36% 32% 0.913 33%
aRetrieved from the life-tables.
95% CI, 95% confidence interval; OS, overall survival; BPI, Basingstoke Predictive Index; NA, not applicable.
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≥ 10 mm (Group 4) obtained a 5-year survival rate of 45%.
However, this difference was not significant. Patients with margins
of intermediate width (Groups 2 and 3) did not demonstrate any
differences with either of the other groups in terms of oncologic
outcome. In the present study, patient survival corresponded with
preoperative patient scoring rather than margin status or margin
width.
The availability of modern, energy-based surgical instruments
for parenchymal transection may represent a possible explana-
tion. The use of electrosurgical instruments induces thermal
damage to surrounding tissue, which may provide an additional
zone of tissue necrosis adjacent to the specimen to be resected.
The traditional Kelly clamp crushing technique identifies
intraparenchymal structures to be divided without the same
thermal tissue damage.25 Thus, as a result of the thermal damage
that is likely to have occurred in this series, the true resection
margins may be several millimetres wider than those estimated by
the pathologist. Correspondingly, pathologists are at risk of
reporting a radical resection margin as positive. This may partly
explain why the present results seem to contradict the ‘1-cm rule’.
Further indirect confirmation of this suggestion is provided by the
growing number of publications in which average resection
margins reported for both open and laparoscopic liver resection
have decreased in recent years.17,19,20,22,29,30 This may primarily
reflect a slight change in the attitudes of hepatopancreatobiliary
surgeons, but it may also point to a histopathologic underestima-
tion of the resection margins that result from the thermal damage
discussed earlier.
Modern energy-based surgical instruments were introduced
early in the development of laparoscopic liver resection and their
use in open surgery may be less frequent.
In the present series, the frequency of local recurrence in the
resection bed is too low to support any definite conclusions
regarding potential differences between the subgroups; it is
obvious that the numbers are small and a much larger study is
required to verify the present results. According to the hypoth-
esized thermal margin, the present authors can only speculate that
the true resection margin in the majority of the current patients
was actually wider than measured because it was adjusted by
thermal injury caused by energy-based instruments.
It should be noted that patients in Group 1 were more likely to
have two or more liver metastases than those in Group 4 (42.4%
versus 16.7%). Several previous studies have shown that a high
number of tumours correlates with reduced disease-free survival,
liver recurrence-free survival and overall survival.31 This tendency
may partly explain the higher rate of hepatic recurrence in Group
1 compared with Group 4 (42.4% versus 22.2%).
Interestingly, the rate of repeat liver resection was significantly
higher in Group 1 than in Group 4. This correlates with the higher
rate of hepatic recurrence in this group. After parenchyma-
sparing liver surgery, repeat resections can be safely performed
laparoscopically with good oncologic outcomes.23
Rates of local liver recurrence after the resection of colorectal
liver metastases have not been reported in laparoscopic liver resec-
tion and have been poorly reported in the setting of open liver
resection.32,33 Although the present sample numbers are small, the
rate of local liver recurrence revealed in this series is lower than
most rates reported for open liver resection.
Understanding the contemporary discordance between real
margin status and that reported by the pathologist may have con-
sequences for both surgeons and pathologists. This emphasizes
the importance of collaboration between surgeons and patholo-
gists in further studies on the topic. The survival rates observed in
the present study were better than predicted by both the preop-
erative and postoperative BPIs. Although this underestimation of
survival was more remarkable across the whole patient cohort for
the preoperative (10%) rather than postoperative (7%) BPI, post-
operative BPIs provided gross underestimations, particularly with
regard to the group of patients with resection margins of < 1 mm
(23%), which may reflect the fact that margin status is a major
Table 4 Recurrence in the liver in patients submitted to laparoscopic liver resection for colorectal metastasis
Parameters Group 1 (n = 33) Group 2
(margin:
≥ 1 mm to
< 3 mm)
(n = 31)
Group 3
(margin:
≥ 3 mm to
< 10 mm
(n = 55)
Group 4
(margin:
≥ 10 mm)
(n = 36)
P-value Total
(n = 155)
1a (positive
margin)
(n = 17)
1b (margin:
> 0 mm to
< 1 mm)
(n = 16)
Overall recurrence, n (%) 17 (51.5%) 11 (35.5%) 28 (50.9%) 17 (47.2%) 0.316 73 (47.1%)
8 (47.1%) 9 (56.3%)
Recurrence in the liver,
n (%)
14 (42.4%) 10 (32.3%) 19 (34.5%) 8 (22.2%) 0.349 51 (32.9%)
7 (41.2%) 7 (43.7%)
Recurrence including local
(margin), n (%)
2 (6.1%) 0 1 (1.8%) 0 0.232 3 (1.9%)
1 (5.9%) 1 (6.3%)
Re-resection for recurrence
in the liver, n (%)
13 (92.9% of all recurrences in the liver) 5 (50.0%) 9 (47.4%) 3 (37.5%) 0.023 30 (58.8%)
6 (85.7%) 7 (100%)
Ablation for recurrence in
the liver, n (%)
1 (7.1% of all recurrences in the liver) 1 (10.0%) 1 (5.3%) 3 (37.5%) 0.102 6 (11.8%)
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scoring factor in the postoperative BPI. Thus it would seem that in
order to provide a more precise survival prognosis, preoperative
BPI is preferable to postoperative BPI for routine use.
In a recently published series of laparoscopic liver resections,
Buell et al. compared stapler resection and electrosurgical resec-
tion.34 They reported equivalent recurrence and survival rates in
the two groups. By contrast with the present series, both groups in
the earlier study34 demonstrated a wide median margin (10 mm
and 15 mm, respectively). Further, local recurrences in the resec-
tion bed were not specifically addressed. Therefore, it was impos-
sible to evaluate the significance of very narrow resection margins
in this study.
Although the present study provides additional data on the topic,
the impact of a narrow resection margin on patient survival after
modern, energy-based liver resection is controversial. The sample
size per group in the present study was small and thus the study
carries a possibility of type II error. The low rate of local liver
recurrences and the difference in the number of metastatic lesions
may have influenced the study outcome. Local recurrences after
parenchyma-sparing liver resections are frequently resectable. This
may also contribute to the low impact of local recurrence on survival.
When modern surgical equipment which generates an addi-
tional zone of coagulation is applied, the association between
resection margin and survival may not be apparent. This does not
mean that surgeons should not try to avoid a positive or very
narrow resection margin whenever possible. However, the present
authors believe that the findings of this study support the perfor-
mance of liver resection even in patients in whom the resection
margin expected is < 10 mm in width.
Additional studies of both an experimental and a clinical nature
are necessary to further define the role of the microscopically
involved resection margin in oncologic outcomes after liver resec-
tion with modern parenchymal dissection techniques.
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